Latest News
BP Stock Gains on Oil Price Surge, Yet Market Skepticism Lingers Over Lasting Impact
BP's stock climbed 2.2% in London trading following a sharp spike in oil prices, though the gain significantly lags behind crude's over 40% surge since late last month, reflecting market doubts about sustained supply disruptions.
Rio Tinto Bauxite Diverted Amid Hormuz Blockage, Aluminium Prices Surge
A Rio Tinto bauxite cargo from Australia has been diverted to China following a blockage in the Strait of Hormuz, contributing to a spike in aluminium prices as Gulf smelters face supply shortages.
Rolls-Royce Deepens Polish Defense Partnership Amid European Arms Surge
Rolls-Royce has entered a preliminary agreement with Poland's state-backed defense group PGZ to broaden collaboration on propulsion systems for military land and sea platforms. The move aligns with a significant increase in European arms imports and Poland's push to access EU military funding.
BlackRock Fund Limits Spark Liquidity Fears as Private Credit Defaults Hit Record
BlackRock has restricted redemptions from its $26 billion private-credit fund after requests surged, intensifying stress in real estate-linked markets. Fitch warns of record defaults in the sector.
Opendoor's Aggressive 4.99% Mortgage Beta Tests Profitability Path
Opendoor Technologies introduced a beta mortgage product with a 4.99% rate to stimulate transactions, as the iBuyer works to achieve profitability by late 2026 following significant annual losses.
UiPath Shares Dip Ahead of Q4 Report Amid AI Strategy Scrutiny
UiPath shares fell slightly on Monday as the market awaits the company's fourth-quarter results, focusing on whether its new AI tools can drive sustainable growth amid rising competition.
Micron Stock Gains on Analyst Upgrades Despite Nvidia HBM4 Setback
Micron Technology shares advanced Monday after analysts lifted price targets, even as reports indicated Nvidia's upcoming Vera Rubin AI platform will source HBM4 memory from rivals Samsung and SK Hynix.
Pfizer's Eczema Candidate Tilrekimig Advances, Eyes Dupixent Rivalry
Pfizer announced its experimental eczema drug tilrekimig achieved its main goal in a mid-stage study, showing significant symptom improvement. The company plans to initiate a pivotal Phase 3 trial later this year.
Nokia Shares Dip Amid AI Network Push and Divergent Analyst Views
Nokia's stock edged lower in Helsinki trading as the telecom equipment maker pushes forward with AI-integrated network technology. Brokerage firms are divided on the stock's outlook, with mixed price targets ahead of its upcoming earnings report.
Zoox Expands Robotaxi Testing to Dallas and Phoenix Amid Intensifying U.S. Autonomous Race
Zoox, Amazon's autonomous vehicle unit, is launching test operations in Dallas and Phoenix, bringing its U.S. test markets to 10. The expansion includes a new operations center and hundreds of jobs.
U.S. Art Auction Sales Surge 23% in 2025, Led by Established Artists
U.S. art auction sales at top houses rose 23% to $3.17 billion in 2025, the first annual gain since 2022, according to Bank of America. The rebound was fueled by historical artists and a focus on quality.